Ngā hua rapu - Erin D. Michos

Whakamahine hua
  1. 1
    Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.

    Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S. mā Erin D. Michos, Roger S. Blumenthal

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies

    Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies mā Pamela L. Lutsey, Erin D. Michos

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey

    The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey mā Mohsen Mazidi, Erin D. Michos, Maciej Banach

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

    Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention mā Olatokunbo Osibogun, Oluseye Ogunmoroti, Erin D. Michos

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic

    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic mā Eamon Duffy, Miguel Cainzos‐Achirica, Erin D. Michos

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis

    Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis mā Yash Maniar, Ahmad Al‐Abdouh, Erin D. Michos

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity

    Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity mā Erin D. Michos, Francisco López-Jiménez, Martha Gulati

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Hormone Replacement Therapy and the Cardiovascular System

    Hormone Replacement Therapy and the Cardiovascular System mā Pamela Ouyang, Erin D. Michos, Richard H. Karas

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention

    Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention mā Petal Elder, Garima Sharma, Martha Gulati, Erin D. Michos

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    COVID and Cardiovascular Disease: What We Know in 2021

    COVID and Cardiovascular Disease: What We Know in 2021 mā Michael Chilazi, Eamon Duffy, Aarti Thakkar, Erin D. Michos

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum

    Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum mā Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?

    A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? mā Alaa Diab, Lily Nedda Dastmalchi, Martha Gulati, Erin D. Michos

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population

    25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population mā Michal L. Melamed, Erin D. Michos, Wendy S. Post, Brad C. Astor

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease

    Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease mā Jared P. Reis, Erin D. Michos, Denise von Mühlen, Edgar R. Miller

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Aspirin and Clopidogrel Resistance

    Aspirin and Clopidogrel Resistance mā Erin D. Michos, Reza Ardehali, Roger S. Blumenthal, Richard A. Lange, Hossein Ardehali

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events

    Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events mā Erin D. Michos, Christopher T. Sibley, Jefferson Baer, Michael J. Blaha, Roger S. Blumenthal

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Adverse pregnancy outcomes and future maternal cardiovascular disease

    Adverse pregnancy outcomes and future maternal cardiovascular disease mā Alisse Hauspurg, Wendy Ying, Carl A. Hubel, Erin D. Michos, Pamela Ouyang

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk

    The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk mā Anandita Agarwala, Erin D. Michos, Zainab Samad, Christie M. Ballantyne, Salim S. Virani

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection mā Erin D. Michos, George L. Bakris, Helena W. Rodbard, Katherine R. Tuttle

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    High lipoprotein(a): Actionable strategies for risk assessment and mitigation

    High lipoprotein(a): Actionable strategies for risk assessment and mitigation mā Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, Wess Boatwright, Christie M. Ballantyne

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: